KLRK1 and sarcoma: Besides the upregulation of tumor suppressor genes and the downregulation of oncogenes, the HDACi can modulate the immune response and enhance the cytotoxicity of NK cells in sarcoma cell lines by increasing the expression of NKG2D [90,91].